Journal of the Chemical Society Chemical Communications · 1983 · 23 citations · 0 references
PharmacyMedicinal ChemistryDrug DiscoveryNatural Product BiosynthesisSynthetic Medicinal ChemistryAntitumor AntibioticsMacrocycle SynthesisAntimicrobial MetabolitesChiral Product SynthesisSpiropyran Compounds
A synthesis of two diprotected (4S, 6S)-4-hydroxy-6-hydroxymethyltetrahydropyran-2-ones has been developed from laevoglucosan; reaction of these lactones with a substituted lithium acetylide derivative followed by hydrogenation and acid catalysed cyclisation has led to formation of the spiroacetal moiety of milbemycin β1 and β3.